|
|
|
|
| LEADER |
01906nam a22002895i 4500 |
| 001 |
000280650 |
| 005 |
20210426112024.0 |
| 007 |
cr nn 008mamaa |
| 008 |
140905s2014 xxu| s |||| 0|eng d |
| 020 |
|
|
|a 9781493912520
|
| 024 |
7 |
|
|a 10.1007/978-1-4939-1252-0
|2 doi
|
| 040 |
|
|
|a Sistema de Bibliotecas del Tecnológico de Costa Rica
|
| 245 |
1 |
0 |
|a FDA Bioequivalence Standards /
|c edited by Lawrence X. Yu, Bing V. Li.
|
| 250 |
|
|
|a 1st ed. 2014.
|
| 260 |
# |
# |
|a New York, NY :
|b Springer New York :
|b Imprint: Springer,
|c 2014.
|
| 300 |
|
|
|a XIII, 465 p. 58 illus., 26 illus. in color. :
|b online resource.
|
| 336 |
|
|
|a text
|b txt
|2 rdacontent
|
| 337 |
|
|
|a computer
|b c
|2 rdamedia
|
| 338 |
|
|
|a online resource
|b cr
|2 rdacarrier
|
| 490 |
1 |
|
|a AAPS Advances in the Pharmaceutical Sciences Series,
|v 13
|
| 505 |
0 |
|
|a 1 Bioequivalence History -- 2 Fundamentals of Bioequivalence -- 3 Basic Statistical Considerations -- 4 The Effects of Food on Drug Bioavailability and Bioequivalence -- 5 Bio waiver and Biopharmaceutics Classification System -- 6 Bioequivalence of Highly Variable Drugs -- 7 Partial Area under the Curve: An Additional Pharmacokinetic Metric for Bioavailability and Bioequivalence Assessments -- 8 Bioequivalence for Narrow Therapeutic Index Drugs -- 9 Pharmacodynamic Endpoint-based Bioequivalence Studies -- 10 Clinical Endpoint Bioequivalence Study -- 11 Bioequivalence for Liposomal Drug Products -- 12 Bioequivalence for Drug Products Acting Locally within Gastrointestinal Tract -- 13 Bioequivalence for Topical Drug Products -- 14 Bioequivalence for Orally Inhaled and Nasal Drug Products -- 15 Bioequivalence: Modeling and Simulation -- 16 Bioanalysis.
|
| 650 |
|
0 |
|a Pharmaceutical technology.
|
| 650 |
1 |
4 |
|a Pharmaceutical Sciences/Technology.
|
| 700 |
1 |
|
|a Yu, Lawrence X.
|e editor.
|
| 700 |
1 |
|
|a Li, Bing V.
|e editor.
|
| 710 |
2 |
|
|a SpringerLink (Online service)
|
| 773 |
0 |
|
|t Springer eBooks
|